Metraipolis › archive › dc_ceddb4ace26c
Cost-Effectiveness and Evidence Gaps Surrounding PSMA-PET for Recurrent Prostate Cancer Evaluation — Europe PMC PMID:41134573
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41134573
- DOI
- 10.1001/jamanetworkopen.2025.39250
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T16:30:49.343Z
- SHA-256 of the archived text
355ac7d17cc7c4ea8444823cd54a824b1932d2d824e223f51a6f44a1f6614c25- Stable URL of this page
https://metraipolis.com/documento/dc_ceddb4ace26c
How to cite
Cost-Effectiveness and Evidence Gaps Surrounding PSMA-PET for Recurrent Prostate Cancer Evaluation — Europe PMC PMID:41134573 — Europe PMC (en), https://europepmc.org/article/MED/41134573 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ceddb4ace26c (Metraipolis archive dc_ceddb4ace26c, sha256 355ac7d17cc7c4ea8444823cd54a824b1932d2d824e223f51a6f44a1f6614c25)
BibTeX
@misc{dcceddb4ace26c,
title = {Cost-Effectiveness and Evidence Gaps Surrounding PSMA-PET for Recurrent Prostate Cancer Evaluation — Europe PMC PMID:41134573},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41134573},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ceddb4ace26c; sha256 355ac7d17cc7c4ea8444823cd54a824b1932d2d824e223f51a6f44a1f6614c25},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41134573. Agents can read the archived copy with the MCP tool read_document.